New C3⁺ device for long-term ECG-recording launched at the European Society of Cardiology Congress in Paris.

The new C3+ Holter Monitor features flexible arms and offers real-time preview of the 3 channel ECG via an app (iOS). In addition, recordings of up to 7 days can be selected. The device is attached to the patient’s chest with standard ECG electrodes. It has no cables and delivers excellent signal quality. The C3+Holter Monitor solution was designed to offer fast and accurate diagnoses of cardiac arrhythmias. “The time-consuming ECG analysis is outsourced, so that the practice operation is optimized, says Dr. W. Geissler, a general practitioner in Möhringen, Germany.

Why would doctors choose the C3+for recording?

Atrial fibrillation (AF) is the most common cardiac arrhythmia in the general population.1Undiagnosed AF increases the risk of stroke fivefold.2AF is the leading cause of stroke, heart attack and mortality.3This risk can be reduced by early diagnosis and timely treatment.2There are currently about 10 million AF patients in Europe with a population of 500 million, and 100,000-200,000 new cases are diagnosed every year.4The prevalence of AF is increasing annually at an expected rate comparable to Iceland of 0.04%4. AF is expected to affect 14-17 million patients and 215,000 new cases per year in 2030 in Europe alone.3

Innovative technologies, such as the C3+Holter Monitor, can simplify and accelerate the diagnosis of AF. This device makes arrhythmia screening easy and convenient for both the physician and the patient. In the event of cardiac arrhythmia, the physician can quickly initiate the necessary treatment to reduce the risk of serious illness.

(1) Bouwe P. Krijthe, Anton Kunst, Emelia J. Benjamin, Gregory Y.H. Lip, Oscar H. Franco, Albert Hofman, Jacqueline C.M. Witteman, Bruno H. Stricker, Jan Heeringa; Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060, European Heart Journal, Volume 34, Issue 35, 14 September 2013, Pages 2746–2751

(2) Camm AJ et al.: E.S.C. Committee for Practice Guidelines. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33(21): 2719–47.

(3) Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., … & Hindricks, G. (2016). 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European heart journal, 37(38), 2893-2962.

(4) Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014;6:213-20.